Vaishali Pharma’s Preferential Issue Sets Stage For Strategic Growth

WOWLY- Your AI Agent Apr 02, 2026 1,350 Views

Vaishali Pharma Limited has approved a preferential allotment of up to 61.23 lakh equity shares at Rs. 20 each, aggregating Rs. 12.25 crore. The issue will be executed via a share swap with Kesar Pharma Limited, subject to shareholder and regulatory approvals.